Clinical trials recruiting in Aveiro, Portugal

Phase breakdown

Conditions recruiting in Aveiro, Portugal

Recruiting trials in Aveiro, Portugal

• A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
  NCT06056297 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
  NCT06486883 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Validation of the C-mo System - Cough Monitoring
  NCT05989698 · Phase: Not applicable (e.g. observational or device study) · Ages: 2 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Aveiro, Portugal?

5 recruiting trials have at least one study site in Aveiro, Portugal.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.